Baidu Ventures has re-upped its commitment to the DNA and RNA sequencing equipment manufacturer, joining investors including Sunshine Insurance’s Riverhead Capital vehicle.

China-based genomics technology developer QitanTech received RMB400m ($63m) in series B funding yesterday from investors including internet company Baidu and insurance provider Sunshine Insurance Group.

GL Ventures, the venture capital arm of private equity group Hillhouse Capital, co-led the round with CDH Venture and Growth Capital, a fund owned by asset manager CDH Investments.

Alwin Capital, BioTrack Capital, Gaorong Capital, Huagai Capital, Yinxinggu Capital and ZGC Co-Innovation Fund filled out the investors. Baidu was represented by its Baidu Ventures unit…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.